Germany Radiopharmaceuticals Market

ID: MRFR/Pharma/42197-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
Germany Radiopharmaceuticals Market Research Report By Type (Diagnostic, Therapeutic) and By Application (Neurology, Cardiology, Oncology, Others) - Growth & Industry Forecast 2025 To 2035
Germany Radiopharmaceuticals Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)8.26%
2024 Market Size$ 0.6 Billion
2025 Market Size$ 0.65 Billion
2035 Market Size$ 1.43 Billion
Key Players
Siemens Healthineers
Bayer AG
Eckert & Ziegler AG
Curium Pharma
GE Healthcare
Lantheus Medical Imaging
Trends
  • Technological Advancements in Imaging
  • Regulatory Support for Development
  • Focus on Personalized Medicine
Opportunities
  • Growing Demand for Diagnostic Imaging
  • Investment in Research and Development
  • Regulatory Framework Supporting Innovation
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Billion)
      1. 4.1.1 Oncology
      2. 4.1.2 Cardiology
      3. 4.1.3 Neurology
      4. 4.1.4 Thyroid
      5. 4.1.5 Infection
    2. 4.2 Healthcare, BY End Use (USD Billion)
      1. 4.2.1 Hospitals
      2. 4.2.2 Diagnostic Centers
      3. 4.2.3 Research Laboratories
      4. 4.2.4 Pharmaceutical Companies
    3. 4.3 Healthcare, BY Type (USD Billion)
      1. 4.3.1 Diagnostic Radiopharmaceuticals
      2. 4.3.2 Therapeutic Radiopharmaceuticals
      3. 4.3.3 Radioisotopes
      4. 4.3.4 Radiopharmaceutical Generators
    4. 4.4 Healthcare, BY Distribution Channel (USD Billion)
      1. 4.4.1 Direct Sales
      2. 4.4.2 Distributors
      3. 4.4.3 Online Sales
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Siemens Healthineers (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Bayer AG (DE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Eckert & Ziegler AG (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Curium Pharma (FR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 GE Healthcare (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Lantheus Medical Imaging (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Radiopharma (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 NorthStar Medical Radioisotopes (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 GERMANY MARKET ANALYSIS BY APPLICATION
    3. 6.3 GERMANY MARKET ANALYSIS BY END USE
    4. 6.4 GERMANY MARKET ANALYSIS BY TYPE
    5. 6.5 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    14. 6.14 HEALTHCARE, BY END USE, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    16. 6.16 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    18. 6.18 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
      2. 7.2.2 BY END USE, 2026-2035 (USD Billion)
      3. 7.2.3 BY TYPE, 2026-2035 (USD Billion)
      4. 7.2.4 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Germany Radiopharmaceuticals Market Segmentation

Germany Radiopharmaceuticals Market By Application (USD Billion, 2026-2035)

  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
  • Infection

Germany Radiopharmaceuticals Market By End Use (USD Billion, 2026-2035)

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Germany Radiopharmaceuticals Market Companies

Germany Radiopharmaceuticals Market By Type (USD Billion, 2026-2035)

  • Diagnostic Radiopharmaceuticals
  • Therapeutic Radiopharmaceuticals
  • Radioisotopes
  • Radiopharmaceutical Generators

Germany Radiopharmaceuticals Market By Distribution Channel (USD Billion, 2026-2035)

  • Direct Sales
  • Distributors
  • Online Sales

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.